glp 1 inventor We are honoured to welcome Dr. Lotte Bjerre Knudsen as our speaker for #ARDD2025! Lotte is a co-inventor of the long-acting GLP-1, liraglutide, and has led all biology research programs from diabetes Structure Therapeutics CEO on GLP

Cerebrolysin provides more robust structural and functional repair

This decline may be due to the decreased GLP-1 secretion or impairment of L-cell development [15,16,17,18]

Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry

Target stubborn fat, fuel your metabolism, and enhance your energynaturally and effectively

Consequently, patients with diabetes may experience burning, tingling, or stabbing sensations that impair quality of life

The pharmacokinetic parameters of BPC157 did not significantly change after repeated administration of BPC157 compared to those observed after a single IM injection of the same dose administered daily for 7 days